Curated News
By: NewsRamp Editorial Staff
May 08, 2026
NU Skin Shows Early Stabilization as Prysm iO Gains Traction
TLDR
- NU Skin's early field stabilization and Prysm iO adoption suggest a potential turnaround, offering an investment advantage before 2H26 improvement.
- NU Skin's Q1 revenue of $320.6M missed estimates, but adjusted EPS of $0.14 stayed within range due to cost discipline and Prysm iO scaling.
- Prysm iO's nearly 2 million scans and growing subscriptions enhance customer engagement, making wellness more accessible and improving quality of life.
- Nearly 2 million scans on over 30,000 Prysm iO devices show surprising early adoption, hinting at a tech-driven comeback for NU Skin.
Impact - Why it Matters
This news matters because NU Skin's early field stabilization and growth in new sales leaders, driven by the Prysm iO platform, signal a potential turnaround for the company. For investors, the maintained guidance and improving metrics offer a glimmer of hope after a period of declining KPIs. For consumers and brand affiliates, the focus on innovative technology and emerging markets suggests that NU Skin is investing in long-term growth and customer engagement, which could lead to better products and opportunities down the line.
Summary
Stonegate Capital Partners has updated its coverage on NU Skin Enterprises Inc. (NYSE: NUS), following the company's first-quarter 2026 earnings report. NUS reported revenue of $320.6 million, adjusted net income of $6.8 million, and adjusted EPS of $0.14, which came in slightly below Stonegate's estimates of $329.7 million, $7.7 million, and $0.15, respectively. Revenue landed near the low end of management's guidance, while adjusted EPS remained within range as the company continued investing in its innovative Prysm iO platform and expanding into emerging markets, all while maintaining cost discipline. Core Nu Skin gross margin improved 20 basis points year-over-year to 76.9%, though adjusted operating margin fell to 3.6% from 6.4% in the prior year.
The most encouraging sign for investors was management's commentary that brand affiliate confidence is improving, and new sales leaders grew year-over-year as the quarter ended. This suggests early field stabilization as Prysm iO training and leader engagement scale. Key takeaways from the report include Prysm iO's role as the core commercialization catalyst, with nearly 2 million scans across over 30,000 devices indicating early adoption, and a 5% year-over-year increase in subscription volume, which points to improving customer engagement and recurring revenue quality. Despite headline KPIs showing declines—sales leaders down 13%, paid affiliates down 8%, and customers down 14% year-over-year—the improving trend in new sales leaders and brand affiliate confidence signals a potential turnaround.
Looking ahead, NU Skin maintained its full-year 2026 revenue guidance of $1.35 billion to $1.50 billion and adjusted EPS guidance of $0.80 to $1.20, supported by broader Prysm iO adoption, the planned launch in India later this year, and ongoing cost discipline. The company's guidance implies confidence in a second-half 2026 improvement cadence. For more details, including downloadable images and bios, click here to view the full announcement.
Source Statement
This curated news summary relied on content disributed by Reportable. Read the original source here, NU Skin Shows Early Stabilization as Prysm iO Gains Traction
